337 related articles for article (PubMed ID: 21875607)
1. Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration.
Elsworth JD; Groman SM; Jentsch JD; Valles R; Shahid M; Wong E; Marston H; Roth RH
Neuropharmacology; 2012 Mar; 62(3):1442-52. PubMed ID: 21875607
[TBL] [Abstract][Full Text] [Related]
2. Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism.
Snigdha S; Idris N; Grayson B; Shahid M; Neill JC
Psychopharmacology (Berl); 2011 Apr; 214(4):843-53. PubMed ID: 21088957
[TBL] [Abstract][Full Text] [Related]
3. Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat.
McLean SL; Neill JC; Idris NF; Marston HM; Wong EH; Shahid M
Behav Brain Res; 2010 Dec; 214(2):240-7. PubMed ID: 20561963
[TBL] [Abstract][Full Text] [Related]
4. Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits.
Jentsch JD; Taylor JR; Elsworth JD; Redmond DE; Roth RH
Neuroscience; 1999 Mar; 90(3):823-32. PubMed ID: 10218783
[TBL] [Abstract][Full Text] [Related]
5. Serotonin (5-HT)1A receptor agonism and 5-HT7 receptor antagonism ameliorate the subchronic phencyclidine-induced deficit in executive functioning in mice.
Rajagopal L; Massey BW; Michael E; Meltzer HY
Psychopharmacology (Berl); 2016 Feb; 233(4):649-60. PubMed ID: 26558619
[TBL] [Abstract][Full Text] [Related]
6. The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm.
Abdul-Monim Z; Reynolds GP; Neill JC
Behav Brain Res; 2006 May; 169(2):263-73. PubMed ID: 16500717
[TBL] [Abstract][Full Text] [Related]
7. Clozapine normalizes prefrontal cortex dopamine transmission in monkeys subchronically exposed to phencyclidine.
Elsworth JD; Jentsch JD; Morrow BA; Redmond DE; Roth RH
Neuropsychopharmacology; 2008 Feb; 33(3):491-6. PubMed ID: 17507917
[TBL] [Abstract][Full Text] [Related]
8. Prolonged reversal of the phencyclidine-induced impairment in novel object recognition by a serotonin (5-HT)1A-dependent mechanism.
Horiguchi M; Miyauchi M; Neugebauer NM; Oyamada Y; Meltzer HY
Behav Brain Res; 2016 Mar; 301():132-41. PubMed ID: 26342283
[TBL] [Abstract][Full Text] [Related]
9. Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms.
Idris N; Neill J; Grayson B; Bang-Andersen B; Witten LM; Brennum LT; Arnt J
Psychopharmacology (Berl); 2010 Jan; 208(1):23-36. PubMed ID: 19851757
[TBL] [Abstract][Full Text] [Related]
10. PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments.
Castañé A; Santana N; Artigas F
Psychopharmacology (Berl); 2015 Nov; 232(21-22):4085-97. PubMed ID: 25943167
[TBL] [Abstract][Full Text] [Related]
11. TPA-023 attenuates subchronic phencyclidine-induced declarative and reversal learning deficits via GABA
Rajagopal L; Huang M; Michael E; Kwon S; Meltzer HY
Neuropsychopharmacology; 2018 Nov; 43(12):2468-2477. PubMed ID: 30093697
[TBL] [Abstract][Full Text] [Related]
12. The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.
Abdul-Monim Z; Reynolds GP; Neill JC
J Psychopharmacol; 2003 Mar; 17(1):57-65. PubMed ID: 12680740
[TBL] [Abstract][Full Text] [Related]
13. Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow.
Frånberg O; Marcus MM; Svensson TH
Synapse; 2012 Jul; 66(7):650-60. PubMed ID: 22362425
[TBL] [Abstract][Full Text] [Related]
14. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.
Abdul-Monim Z; Neill JC; Reynolds GP
J Psychopharmacol; 2007 Mar; 21(2):198-205. PubMed ID: 17329300
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys.
Jentsch JD; Taylor JR; Redmond DE; Elsworth JD; Youngren KD; Roth RH
Psychopharmacology (Berl); 1999 Feb; 142(1):78-84. PubMed ID: 10102786
[TBL] [Abstract][Full Text] [Related]
16. Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.
McLean SL; Grayson B; Idris NF; Lesage AS; Pemberton DJ; Mackie C; Neill JC
Eur Neuropsychopharmacol; 2011 Apr; 21(4):333-43. PubMed ID: 20630711
[TBL] [Abstract][Full Text] [Related]
17. RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia.
Rajagopal L; Kwon S; Huang M; Michael E; Bhat L; Cantillon M; Meltzer HY
Behav Brain Res; 2017 Aug; 332():180-199. PubMed ID: 28373127
[TBL] [Abstract][Full Text] [Related]
18. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors.
Hagiwara H; Fujita Y; Ishima T; Kunitachi S; Shirayama Y; Iyo M; Hashimoto K
Eur Neuropsychopharmacol; 2008 Jun; 18(6):448-54. PubMed ID: 18164909
[TBL] [Abstract][Full Text] [Related]
19. Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966.
Jentsch JD; Elsworth JD; Redmond DE; Roth RH
J Neurosci; 1997 Mar; 17(5):1769-75. PubMed ID: 9030635
[TBL] [Abstract][Full Text] [Related]
20. The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania.
Tarazi FI; Neill JC
Expert Opin Drug Discov; 2013 Jan; 8(1):93-103. PubMed ID: 23121334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
